1. Home
  2. EXAS
  3. EXAS News

Latest Exact Sciences Corporation (EXAS) News on December 18, 2024

Why Is Mirum Pharmaceuticals (MIRM) Down 0.7% Since Last Earnings Report?
EXAS

Zacks

6 days ago

Why Is Mirum Pharmaceuticals (MIRM) Down 0.7% Since Last Earnings Report?

Pacira (PCRX) Up 5.5% Since Last Earnings Report: Can It Continue?
EXAS

Zacks

12 days ago

Pacira (PCRX) Up 5.5% Since Last Earnings Report: Can It Continue?

Exploring High Growth Tech Stocks in December 2024
EXAS

Simply Wall St.

13 days ago

Exploring High Growth Tech Stocks in December 2024

EXAS

Morningstar Research

22 days ago

Analyst Report: Exact Sciences Corporation

Why Is Exact Sciences Stock Trading Higher On Tuesday? (CORRECTED)
EXAS

Benzinga

22 days ago

Why Is Exact Sciences Stock Trading Higher On Tuesday? (CORRECTED)

EXAS

MT Newswires

22 days ago

BTIG Raises Price Target on Exact Sciences to $75 From $65, Maintains Buy Rating

Exact Sciences to Participate in December Investor Conferences
EXAS

Business Wire

22 days ago

Exact Sciences to Participate in December Investor Conferences

Exact Sciences Advances Breast Cancer Care with the Oncotype DX® test and Genomic Profiling Research at SABCS 2024
EXAS

Business Wire

23 days ago

Exact Sciences Advances Breast Cancer Care with the Oncotype DX® test and Genomic Profiling Research at SABCS 2024

Exact Sciences Corporation (EXAS): Among the Best Genomics Stocks to Buy Right Now
EXAS

Insider Monkey

a month ago

Exact Sciences Corporation (EXAS): Among the Best Genomics Stocks to Buy Right Now

EXAS Stock Set to Benefit From Favorable Study Data Backing MCED Test
EXAS

Zacks

a month ago

EXAS Stock Set to Benefit From Favorable Study Data Backing MCED Test

Chairman of The Board & CEO of Exact Sciences Picks Up 2.7% More Stock
EXAS

Simply Wall St.

a month ago

Chairman of The Board & CEO of Exact Sciences Picks Up 2.7% More Stock

Exact Sciences showcases early cancer detection test data at AACR meeting
EXAS

Clinical Trials Arena

a month ago

Exact Sciences showcases early cancer detection test data at AACR meeting

EXAS

Argus Research

a month ago

Daily – Vickers Top Buyers & Sellers for 11/14/2024

EXAS

MT Newswires

a month ago

Exact Sciences Insider Bought Shares Worth $1,001,325, According to a Recent SEC Filing

Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy
EXAS

Business Wire

a month ago

Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy

Exact Sciences Corporation (EXAS) Rebounded from the Previous Quarter
EXAS

Insider Monkey

a month ago

Exact Sciences Corporation (EXAS) Rebounded from the Previous Quarter

Exact Sciences’ forecast cut shocks analysts
EXAS

MedTech Dive

a month ago

Exact Sciences’ forecast cut shocks analysts

Guardant Health Pops 13% On An 'Impressive' Beat Following Exact Sciences' Flop
EXAS

Investor's Business Daily

a month ago

Guardant Health Pops 13% On An 'Impressive' Beat Following Exact Sciences' Flop

Exact Sciences Third Quarter 2024 Earnings: Misses Expectations
EXAS

Simply Wall St.

a month ago

Exact Sciences Third Quarter 2024 Earnings: Misses Expectations

Exact Sciences Collapses On 'Alarming' Guidance Cut. Is The Growth Story Broken?
EXAS

Investor's Business Daily

a month ago

Exact Sciences Collapses On 'Alarming' Guidance Cut. Is The Growth Story Broken?

Cologuard Maker Exact Sciences Slashes Outlook as Losses Mount
EXAS

Investopedia

a month ago

Cologuard Maker Exact Sciences Slashes Outlook as Losses Mount

EXAS

Morningstar Research

a month ago

Analyst Report: Exact Sciences Corporation

Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point
EXAS

Benzinga

a month ago

Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point

Exact Sciences Stock Down on Q3 Earnings & Revenue Miss, '24 View Cut
EXAS

Zacks

a month ago

Exact Sciences Stock Down on Q3 Earnings & Revenue Miss, '24 View Cut

EXAS

Thomson Reuters StreetEvents

a month ago

Q3 2024 Exact Sciences Corp Earnings Call

Exact Sciences Corp (EXAS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
EXAS

GuruFocus.com

a month ago

Exact Sciences Corp (EXAS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...

Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight
EXAS

GuruFocus.com

a month ago

Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight

Exact Sciences Stock Falls 29% On Weak Results, Downbeat Outlook
EXAS

Investor's Business Daily

a month ago

Exact Sciences Stock Falls 29% On Weak Results, Downbeat Outlook

Exact Sciences (EXAS) Q3 2024 Earnings Call Transcript
EXAS

Motley Fool

a month ago

Exact Sciences (EXAS) Q3 2024 Earnings Call Transcript

Exact Sciences (EXAS) Reports Q3 Loss, Lags Revenue Estimates
EXAS

Zacks

a month ago

Exact Sciences (EXAS) Reports Q3 Loss, Lags Revenue Estimates

EXAS

MT Newswires

a month ago

Exact Sciences Swings to Q3 Loss, Revenue Rises; 2024 Sales Outlook Cut

EXAS

Associated Press Finance

a month ago

Exact Sciences: Q3 Earnings Snapshot

Exact Sciences Announces Third-Quarter 2024 Results
EXAS

Business Wire

a month ago

Exact Sciences Announces Third-Quarter 2024 Results

High Growth Tech Stocks to Watch in November 2024
EXAS

Simply Wall St.

a month ago

High Growth Tech Stocks to Watch in November 2024

3 Large-Cap Stocks to Buy Ahead of Likely Earnings Beat Tuesday
EXAS

Zacks

a month ago

3 Large-Cap Stocks to Buy Ahead of Likely Earnings Beat Tuesday

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
EXAS

Zacks

a month ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Exact Sciences to Participate in November Investor Conference
EXAS

Business Wire

2 months ago

Exact Sciences to Participate in November Investor Conference

Exact Sciences (EXAS) Moves to Strong Buy: Rationale Behind the Upgrade
EXAS

Zacks

2 months ago

Exact Sciences (EXAS) Moves to Strong Buy: Rationale Behind the Upgrade

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
EXAS

Zacks

2 months ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Exact Sciences Presents Multiple Studies at ACG 2024 Demonstrating Leadership in Noninvasive Colorectal Cancer Screening and Patient Engagement
EXAS

Business Wire

2 months ago

Exact Sciences Presents Multiple Studies at ACG 2024 Demonstrating Leadership in Noninvasive Colorectal Cancer Screening and Patient Engagement

Will Screening Sales Drive Exact Sciences' Q3 Earnings?
EXAS

Zacks

2 months ago

Will Screening Sales Drive Exact Sciences' Q3 Earnings?

Can This Beaten-Down Cathie Wood Stock Bounce Back?
EXAS

Motley Fool

2 months ago

Can This Beaten-Down Cathie Wood Stock Bounce Back?

Exact Sciences Corporation (EXAS) Bounced Back in Q3
EXAS

Insider Monkey

2 months ago

Exact Sciences Corporation (EXAS) Bounced Back in Q3

EXAS Gains FDA Nod for Cologuard Plus, Progresses With CRC Screening
EXAS

Zacks

2 months ago

EXAS Gains FDA Nod for Cologuard Plus, Progresses With CRC Screening

Exact Sciences Corp (EXAS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...
EXAS

GuruFocus.com

2 months ago

Exact Sciences Corp (EXAS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Exact Sciences Schedules Third Quarter 2024 Earnings Call
EXAS

Business Wire

2 months ago

Exact Sciences Schedules Third Quarter 2024 Earnings Call

FMR LLC Bolsters Stake in Exact Sciences Corp
EXAS

GuruFocus.com

2 months ago

FMR LLC Bolsters Stake in Exact Sciences Corp

FDA greenlights Exact Science’s newest home colorectal cancer test
EXAS

Medical Device Network

2 months ago

FDA greenlights Exact Science’s newest home colorectal cancer test

High Growth Tech Stocks in the United States for October 2024
EXAS

Simply Wall St.

2 months ago

High Growth Tech Stocks in the United States for October 2024

Exact Sciences wins FDA approval for Cologuard Plus colorectal cancer test
EXAS

MedTech Dive

2 months ago

Exact Sciences wins FDA approval for Cologuard Plus colorectal cancer test

Exact Sciences Corporation (EXAS): A Buzzing AI Health Stock to Add to Your Portfolio
EXAS

Insider Monkey

2 months ago

Exact Sciences Corporation (EXAS): A Buzzing AI Health Stock to Add to Your Portfolio

FDA Clears Exact Sciences' Next-Generation Colorectal Cancer Diagnostic Test
EXAS

Benzinga

2 months ago

FDA Clears Exact Sciences' Next-Generation Colorectal Cancer Diagnostic Test

Exact Sciences Stock Rises After FDA Signs Off On New Cologuard
EXAS

Investor's Business Daily

2 months ago

Exact Sciences Stock Rises After FDA Signs Off On New Cologuard

Is EXAS Stock a Smart Addition to Your Portfolio Right Now?
EXAS

Zacks

2 months ago

Is EXAS Stock a Smart Addition to Your Portfolio Right Now?

EXAS

MT Newswires

2 months ago

Exact Sciences Receives FDA Approval for Multitarget Stool DNA Test

FDA Approves Exact Sciences’ Cologuard Plus Test, Setting a New Benchmark in Non-Invasive Colorectal Cancer Screening
EXAS

Business Wire

2 months ago

FDA Approves Exact Sciences’ Cologuard Plus Test, Setting a New Benchmark in Non-Invasive Colorectal Cancer Screening

How to Find Strong Buy Medical Stocks Using the Zacks Rank
EXAS

Zacks

3 months ago

How to Find Strong Buy Medical Stocks Using the Zacks Rank

EXAS

Morningstar Research

3 months ago

Analyst Report: Exact Sciences Corporation

The Battle Brewing Over Blood Tests for Cancer
EXAS

The Wall Street Journal

3 months ago

The Battle Brewing Over Blood Tests for Cancer

Exact Sciences says data support its colon cancer blood test
EXAS

MedTech Dive

3 months ago

Exact Sciences says data support its colon cancer blood test

ESMO 2024: Exact Sciences unveils results from cancer algorithm trial
EXAS

Medical Device Network

3 months ago

ESMO 2024: Exact Sciences unveils results from cancer algorithm trial

Exact Sciences Presents Data Demonstrating Advancement in Blood-based Colorectal Cancer Screening at ESMO 2024
EXAS

Business Wire

3 months ago

Exact Sciences Presents Data Demonstrating Advancement in Blood-based Colorectal Cancer Screening at ESMO 2024

Why Is Kodiak Sciences (KOD) Down 8.1% Since Last Earnings Report?
EXAS

Zacks

3 months ago

Why Is Kodiak Sciences (KOD) Down 8.1% Since Last Earnings Report?

EXAS

Morningstar Research

3 months ago

Analyst Report: Exact Sciences Corporation

Should You Hold Exact Sciences Corporation (EXAS)?
EXAS

Insider Monkey

3 months ago

Should You Hold Exact Sciences Corporation (EXAS)?

Wall Street Analysts Believe Exact Sciences (EXAS) Could Rally 34.33%: Here's is How to Trade
EXAS

Zacks

3 months ago

Wall Street Analysts Believe Exact Sciences (EXAS) Could Rally 34.33%: Here's is How to Trade

Editas (EDIT) Down 17% Since Last Earnings Report: Can It Rebound?
EXAS

Zacks

3 months ago

Editas (EDIT) Down 17% Since Last Earnings Report: Can It Rebound?

Exact Sciences (EXAS) Up 7.5% Since Last Earnings Report: Can It Continue?
EXAS

Zacks

4 months ago

Exact Sciences (EXAS) Up 7.5% Since Last Earnings Report: Can It Continue?

Exploring Three High Growth Tech Stocks In The United States
EXAS

Simply Wall St.

4 months ago

Exploring Three High Growth Tech Stocks In The United States

EXAS

MT Newswires

4 months ago

Wells Fargo Global Initiates Exact Sciences at Overweight With $75 Price Target

Exact Sciences to Participate in September Investor Conferences
EXAS

Business Wire

4 months ago

Exact Sciences to Participate in September Investor Conferences

Should You Believe in the Growth Potential of Exact Sciences Corporation (EXAS)?
EXAS

Insider Monkey

4 months ago

Should You Believe in the Growth Potential of Exact Sciences Corporation (EXAS)?

Does Exact Sciences (EXAS) Have the Potential to Rally 34.13% as Wall Street Analysts Expect?
EXAS

Zacks

4 months ago

Does Exact Sciences (EXAS) Have the Potential to Rally 34.13% as Wall Street Analysts Expect?

Exact Sciences (EXAS) Rides on Cologuard Sales, New Launches
EXAS

Zacks

4 months ago

Exact Sciences (EXAS) Rides on Cologuard Sales, New Launches

Exact Sciences (EXAS) Enrolls First Patient in Pivotal MCED Study
EXAS

Zacks

4 months ago

Exact Sciences (EXAS) Enrolls First Patient in Pivotal MCED Study

Here’s Why Baron Opportunity Fund Sold its Stake in Exact Sciences Corp (EXAS)
EXAS

Insider Monkey

4 months ago

Here’s Why Baron Opportunity Fund Sold its Stake in Exact Sciences Corp (EXAS)

Exact Sciences kicks off multi-cancer detection study
EXAS

Medical Device Network

4 months ago

Exact Sciences kicks off multi-cancer detection study

Exact Sciences Announces First Patient Enrolled in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence Study
EXAS

Business Wire

4 months ago

Exact Sciences Announces First Patient Enrolled in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence Study

EXAS

Medical Device Network

4 months ago

Exact Sciences data finds Cologuard detected almost 600k cancer cases

New Modeling Data Show the Cologuard® Test Has Detected More Than 623,000 Cancers and Precancers Over Past Decade, Saving U.S. Health Care System $22 Billion
EXAS

Business Wire

4 months ago

New Modeling Data Show the Cologuard® Test Has Detected More Than 623,000 Cancers and Precancers Over Past Decade, Saving U.S. Health Care System $22 Billion

Why You Should Add Exact Sciences (EXAS) to Your Portfolio
EXAS

Zacks

4 months ago

Why You Should Add Exact Sciences (EXAS) to Your Portfolio

The Zacks Analyst Blog Highlights Nomura Research Institute, Manhattan Associates and Exact Sciences
EXAS

Zacks

4 months ago

The Zacks Analyst Blog Highlights Nomura Research Institute, Manhattan Associates and Exact Sciences

Looking for Medical Stocks? The Zacks Rank Can Help You Find Winners
EXAS

Zacks

4 months ago

Looking for Medical Stocks? The Zacks Rank Can Help You Find Winners

Wall Street Analysts Predict a 45.04% Upside in Exact Sciences (EXAS): Here's What You Should Know
EXAS

Zacks

4 months ago

Wall Street Analysts Predict a 45.04% Upside in Exact Sciences (EXAS): Here's What You Should Know

Exact Sciences Corporation (NASDAQ:EXAS) Just Released Its Second-Quarter Earnings: Here's What Analysts Think
EXAS

Simply Wall St.

5 months ago

Exact Sciences Corporation (NASDAQ:EXAS) Just Released Its Second-Quarter Earnings: Here's What Analysts Think

Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight
EXAS

GuruFocus.com

5 months ago

Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight

Why Exact Sciences, Up 27%, Is 'Coiled To Snap Back' After Quarterly Beat
EXAS

Investor's Business Daily

5 months ago

Why Exact Sciences, Up 27%, Is 'Coiled To Snap Back' After Quarterly Beat

EXAS

MT Newswires

5 months ago

Update: Exact Sciences Shares Surge After Q2 Beat, License Agreement With TwinStrand

EXAS

Morningstar Research

5 months ago

Analyst Report: Exact Sciences Corporation

Exact Sciences (EXAS) Q2 Loss Narrower Than Expected, Sales Beat
EXAS

Zacks

5 months ago

Exact Sciences (EXAS) Q2 Loss Narrower Than Expected, Sales Beat

Exact Sciences (EXAS) Q2 2024 Earnings Call Transcript
EXAS

Motley Fool

5 months ago

Exact Sciences (EXAS) Q2 2024 Earnings Call Transcript

Exact Sciences (EXAS) Reports Q2 Loss, Tops Revenue Estimates
EXAS

Zacks

5 months ago

Exact Sciences (EXAS) Reports Q2 Loss, Tops Revenue Estimates

EXAS

Associated Press Finance

5 months ago

Exact Sciences: Q2 Earnings Snapshot

EXAS

MT Newswires

5 months ago

Exact Sciences Q2 Loss Narrows, Revenue Rises; Shares Jump After Hours; TwinStrand's Patent Estate Licensed

Exact Sciences Announces Second-Quarter 2024 Results
EXAS

Business Wire

5 months ago

Exact Sciences Announces Second-Quarter 2024 Results

TwinStrand Biosciences and Exact Sciences Announce Exclusive License Agreement for Duplex Sequencing Technology
EXAS

PR Newswire

5 months ago

TwinStrand Biosciences and Exact Sciences Announce Exclusive License Agreement for Duplex Sequencing Technology

Blueprint Medicines (BPMC) Expected to Beat Earnings Estimates: Should You Buy?
EXAS

Zacks

5 months ago

Blueprint Medicines (BPMC) Expected to Beat Earnings Estimates: Should You Buy?

Exact Sciences (EXAS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
EXAS

Zacks

5 months ago

Exact Sciences (EXAS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Exact Sciences Corporation (EXAS) Slipped Over Investors’ Concerns
EXAS

Insider Monkey

5 months ago

Exact Sciences Corporation (EXAS) Slipped Over Investors’ Concerns

Geneoscopy’s ColoSense deemed reliable in published study
EXAS

Medical Device Network

5 months ago

Geneoscopy’s ColoSense deemed reliable in published study

Share on Social Networks: